Connect with us

Science

A Fungi Pioneer’s Lifelong Work on Exhibit

Published

on

A Fungi Pioneer’s Lifelong Work on Exhibit

On an early summer day in 1876 near Druid Hill Park in Baltimore, a middle-aged woman carrying three large, putrid mushrooms repulsed fellow travelers riding a horse-drawn trolley car.

Even wrapped in paper, the stench of the aptly named stinkhorn mushrooms was overpowering, but the woman stifled a laugh upon overhearing two other passengers gripe about the swarm of flies around them. The smell didn’t bother her. All she cared about was getting the specimens home to study them, she would later write.

This was Mary Elizabeth Banning, a self-taught mycologist who, over the course of nearly four decades, conducted seminal research on the fungi of her state, Maryland.

Miss Banning characterized thousands of specimens that she found in Baltimore and the surrounding countryside, identifying 23 species new to science at the time.

A gifted artist, she collected these observations into a manuscript called “The Fungi of Maryland.” It consisted of 175 stunning watercolor plates, each an accurate yet intimate portrait of a given species, along with detailed scientific descriptions and anecdotes about collecting the mushrooms.

Advertisement

The manuscript was Miss Banning’s life’s work, and she yearned to see it published. But it ended up in a drawer at the New York State Museum in Albany, forgotten for almost a century.

A selection of her watercolors makes up the backbone of an exhibition at the museum that opened this month and runs until Jan. 4 of next year. The exhibition, called “Outcasts,” recognizes Miss Banning’s long-overlooked scientific legacy as well as the museum’s mycology collection, which is one of the most historically significant in the country, according to Patricia Ononiwu Kaishian, the museum’s mycology curator, who conceived the exhibition.

Miss Banning called fungi “vegetable outcasts.” Back then (and all the way until 1969) fungi were classified as a peculiar type of plant. Most botanists from the mid-19th century viewed their study as a research backwater.

Miss Banning herself was an outcast. “She wanted very much to be part of the scientific community,” said John Haines, who was the museum’s mycology curator until he retired in 2005 and who has extensively researched her history. But as a woman living in the 19th century, that path was largely closed to her.

Similar to contemporaries such as Beatrix Potter, who also sought to make her mark on the emerging field of mycology, “the sentiment was, ‘Well, you go home and make your pictures,’” Dr. Haines said.

Advertisement

One scientist did give her the time of day: Charles Horton Peck, who worked at the museum as New York’s first state botanist from 1868 to 1913. Mr. Peck, a pre-eminent figure in American mycology, dedicated most of his career to fungi, collecting more than 33,000 specimens in surveys across New York and describing more than 2,700 new species in his annual reports.

“A lot of the fungi that people recognize from New York or from the Northeast are ones that Peck described,” Dr. Kaishian said.

Miss Banning first wrote Mr. Peck in 1878, asking for feedback on her manuscript. Unlike other scientists she had tried to contact, he wrote back, and they corresponded for nearly 20 years. Her letters, some of which are exhibited, offer a window into their relationship.

“You are my only friend in the debatable land of fungi,” she wrote to him in 1879. She chronicled her collecting forays and scientific observations, and relayed her dreams for the manuscript. “I have a powerful will,” she wrote in 1889. “I have made up my mind to brave defeat sooner than not make an effort to have the plants of Maryland published.”

Miss Banning’s letters were often whimsical and passionate. None of Mr. Peck’s letters to her remain, but his tone in other letters suggested he was much more restrained. Nevertheless, he treated Miss Banning like a respected colleague — offering her scientific mentorship, publishing descriptions of species with her support and even naming species after her. Their scientific bond was undeniable.

Advertisement

“This is a love story, but not between the two people — they were both in love with fungi,” Mr. Haines said. A play he wrote about their relationship drawing from Miss Banning’s letters will be performed at the museum on April 4 at a gallery opening event for the exhibition.

Love triangles, though, are especially prone to turning sour. With no publishing prospects of her own in sight, Miss Banning sent her manuscript to Mr. Peck in 1890, hoping that he could publish it. “He would have had the resources to make it a permanent part of the mycological record,” Dr. Kaishian said. But he never did.

Although she expressed how difficult it was to part from the work and begged him to reassure her that he appreciated its contribution to the field, she did not receive such recognition. “It seems to me by her letters that she died without really understanding the legacy, the value of her work,” Dr. Kaishian said.

In one of her last letters to Mr. Peck in 1897, six years before she died, destitute and alone in a rooming house in Virginia, Miss Banning lamented the book’s loss. “I hardly know how I ever came to part with my illustrated book,” she wrote. “To tell you the truth, I long to see it and call it my own once more, but this could never be.”

“That just still brings tears to my eyes,” Dr. Haines said.

Advertisement

It was Dr. Haines who originally brought Miss Banning’s manuscript to light.

An eccentric curator showed it to him when he visited the museum for a job interview in 1969. He recalls being dazzled by the colors, which were superbly preserved by the fact that the pages had not been open to sunlight for decades.

He exhibited some of the paintings in 1981, and they were shown a few more times, including in Talbot County, Md., where Miss Banning was born. With the help of this spotlight, Miss Banning was inducted into the Maryland Women’s Hall of Fame in 1994. But since the mid-1990s, in part because the pigments degrade quickly in the light, the pictures had been packed away.

Beyond Miss Banning’s work, “Outcasts” gives visitors a glimpse into the broader historical context of mycology. “Fungi are enormously critical organisms that, going back hundreds of millions of years, have shaped the very texture of the earth,” Dr. Kaishian said. “But their stories are still mysterious and often neglected.”

In addition to Miss Banning’s watercolors and letters, the exhibition includes a host of other artifacts and experiences. Visitors can explore one of Peck’s microscopes and mushroom specimens collected by Miss Banning as well as ones collected recently by Dr. Kaishian, or marvel at a set of strikingly realistic wax sculptures of New York fungi made for the museum in 1917 by an artist, Henri Marchand, and his son Paul.

Advertisement

Murals made by museum artists illustrate the biology of fungi, the role they play in the ecosystem and their evolutionary history. A rare fossil of Prototaxites, a 30-foot-tall fungus that lived during the Devonian period about 400 million years ago, points to just how significantly the Earth has changed over time.

Overall, Dr. Kaishian said she hoped that the exhibition demonstrated why natural history collections like this one deserve public support and preservation.

The 150-year-old specimens hidden in cabinets that visitors rarely see help scientists map the limits of different organisms, both geographically and genetically — and that makes it possible to document changes to biological diversity in the face of climate change, for example.

“Natural history collections are active repositories for contemporary research,” Dr. Kaishian said. “There needs to be a lot more science communication about what goes on here and why it matters.”

Advertisement

Science

Trump administration declares ‘war on sugar’ in overhaul of food guidelines

Published

on

Trump administration declares ‘war on sugar’ in overhaul of food guidelines

The Trump administration announced a major overhaul of American nutrition guidelines Wednesday, replacing the old, carbohydrate-heavy food pyramid with one that prioritizes protein, healthy fats and whole grains.

“Our government declares war on added sugar,” Health and Human Services Secretary Robert F. Kennedy Jr. said in a White House press conference announcing the changes. “We are ending the war on saturated fats.”

“If a foreign adversary sought to destroy the health of our children, to cripple our economy, to weaken our national security, there would be no better strategy than to addict us to ultra-processed foods,” Kennedy said.

Improving U.S. eating habits and the availability of nutritious foods is an issue with broad bipartisan support, and has been a long-standing goal of Kennedy’s Make America Healthy Again movement.

During the press conference, he acknowledged both the American Medical Association and the American Assn. of Pediatrics for partnering on the new guidelines — two organizations that earlier this week condemned the administration’s decision to slash the number of diseases that U.S. children are vaccinated against.

Advertisement

“The American Medical Association applauds the administration’s new Dietary Guidelines for spotlighting the highly processed foods, sugar-sweetened beverages, and excess sodium that fuel heart disease, diabetes, obesity, and other chronic illnesses,” AMA president Bobby Mukkamala said in a statement.

Continue Reading

Science

Contributor: With high deductibles, even the insured are functionally uninsured

Published

on

Contributor: With high deductibles, even the insured are functionally uninsured

I recently saw a patient complaining of shortness of breath and a persistent cough. Worried he was developing pneumonia, I ordered a chest X-ray — a standard diagnostic tool. He refused. He hadn’t met his $3,000 deductible yet, and so his insurance would have required him to pay much or all of the cost for that scan. He assured me he would call if he got worse.

For him, the X-ray wasn’t a medical necessity, but it would have been a financial shock he couldn’t absorb. He chose to gamble on a cough, and five days later, he lost — ending up in the ICU with bilateral pneumonia. He survived, but the cost of his “savings” was a nearly fatal hospital stay and a bill that will quite likely bankrupt him. He is lucky he won’t be one of the 55,000 Americans to die from pneumonia each year.

As a physician associate in primary care, I serve as a frontline witness to this failure of the American approach to insurance. Medical professionals are taught that the barrier to health is biology: bacteria, viruses, genetics. But increasingly, the barrier is a policy framework that pressures insured Americans to gamble with their lives. High-deductible health plans seem affordable because their monthly premiums are lower than other plans’, but they create perverse incentives by discouraging patients from seeking and accepting diagnostics and treatments — sometimes turning minor, treatable issues into expensive, life-threatening emergencies. My patient’s gamble with his lungs is a microcosm of the much larger gamble we are taking with the American public.

The economic theory underpinning these high deductibles is known as “skin in the game.” The idea is that if patients are responsible for the first few thousand dollars of their care, they will become savvy consumers, shopping around for the best value and driving down healthcare costs.

But this logic collapses in the exam room. Healthcare is not a consumer good like a television or a used car. My patient was not in a position to “shop around” for a cheaper X-ray, nor was he qualified to determine if his cough was benign or deadly. The “skin in the game” theory assumes a level of medical literacy and market transparency that simply doesn’t exist in a moment of crisis. You can compare the specs of two SUVs; you cannot “shop around” for a life-saving diagnostic while gasping for air.

Advertisement

A 2025 poll from the Kaiser Family Foundation points to this reality, finding that up to 38% of insured American adults say they skipped or postponed necessary healthcare or medications in the past 12 months because of cost. In the same poll, 42% of those who skipped care admitted their health problem worsened as a result.

This self-inflicted public health crisis is set to deteriorate further. The Congressional Budget Office estimates roughly 15 million people will lose health coverage and become uninsured by 2034 because of Medicaid and Affordable Care Act marketplace cuts. That is without mentioning the millions more who will see their monthly premiums more than double if premium tax credits are allowed to expire. If that happens, not only will millions become uninsured but also millions more will downgrade to “bronze” plans with huge deductibles just to keep their premiums affordable. We are about to flood the system with “insured but functionally uninsured” patients.

I see the human cost of this “functional uninsurance” every week. These are patients who technically have coverage but are terrified to use it because their deductibles are so large they may exceed the individuals’ available cash or credit — or even their net worth. This creates a dangerous paradox: Americans are paying hundreds of dollars a month for a card in their wallet they cannot afford to use. They skip the annual physical, ignore the suspicious mole and ration their insulin — all while technically insured. By the time they arrive at my clinic, their disease has often progressed to a catastrophic event, from what could have been a cheap fix.

Federal spending on healthcare should not be considered charity; it is an investment in our collective future. We cannot expect our children to reach their full potential or our workforce to remain productive if basic healthcare needs are treated as a luxury. Inaction by Congress and the current administration to solve this crisis is legislative malpractice.

In medicine, we are trained to treat the underlying disease, not just the symptoms. The skipped visits and ignored prescriptions are merely symptoms; the disease is a policy framework that views healthcare as a commodity rather than a fundamental necessity. If we allow these cuts to proceed, we are ensuring that the American workforce becomes sicker, our hospitals more overwhelmed and our economy less resilient. We are walking willingly into a public health crisis that is entirely preventable.

Advertisement

Joseph Pollino is a primary care physician associate in Nevada.

Insights

L.A. Times Insights delivers AI-generated analysis on Voices content to offer all points of view. Insights does not appear on any news articles.

Viewpoint
This article generally aligns with a Center Left point of view. Learn more about this AI-generated analysis
Perspectives

The following AI-generated content is powered by Perplexity. The Los Angeles Times editorial staff does not create or edit the content.

Ideas expressed in the piece

  • High-deductible health plans create a barrier to necessary medical care, with patients avoiding diagnostics and treatments due to out-of-pocket cost concerns[1]. Research shows that 38% of insured American adults skipped or postponed necessary healthcare or medications in the past 12 months because of cost, with 42% reporting their health worsened as a result[1].

  • The economic theory of “skin in the game”—which assumes patients will shop around for better healthcare values if they have financial responsibility—fails in medical practice because patients lack the medical literacy to make informed decisions in moments of crisis and cannot realistically compare pricing for emergency or diagnostic services[1].

  • Rising deductibles are pushing enrollees toward bronze plans with deductibles averaging $7,476 in 2026, up from the average silver plan deductible of $5,304[1][4]. In California’s Covered California program, bronze plan enrollment has surged to more than one-third of new enrollees in 2026, compared to typically one in five[1].

  • Expiring federal premium tax credits will more than double out-of-pocket premiums for ACA marketplace enrollees in 2026, creating an expected 75% increase in average out-of-pocket premium payments[5]. This will force millions to either drop coverage or downgrade to bronze plans with massive deductibles, creating a population of “insured but functionally uninsured” people[1].

  • High-deductible plans pose particular dangers for patients with chronic conditions, with studies showing adults with diabetes involuntarily switched to high-deductible plans face 11% higher risk of hospitalization for heart attacks, 15% higher risk for strokes, and more than double the likelihood of blindness or end-stage kidney disease[4].

Different views on the topic

  • Expanding access to health savings accounts paired with bronze and catastrophic plans offers tax advantages that allow higher-income individuals to set aside tax-deductible contributions for qualified medical expenses, potentially offsetting higher out-of-pocket costs through strategic planning[3].

  • Employers and insurers emphasize that offering multiple plan options with varying deductibles and premiums enables employees to select plans matching their individual needs and healthcare usage patterns, allowing those who rarely use healthcare to save money through lower premiums[2]. Large employers increasingly offer three or more medical plan choices, with the expectation that employees choosing the right plan can unlock savings[2].

  • The expansion of catastrophic plans with streamlined enrollment processes and automatic display on HealthCare.gov is intended to make affordable coverage more accessible for certain income groups, particularly those above 400% of federal poverty level who lose subsidies[3].

  • Rising healthcare costs, including specialty drugs and new high-cost cell and gene therapies, are significant drivers requiring premium increases regardless of plan design[5]. Some insurers are managing affordability by discontinuing costly coverage—such as GLP-1 weight-loss medications—to reduce premium rate increases for broader plan members[5].

Advertisement
Continue Reading

Science

Trump administration slashes number of diseases U.S. children will be regularly vaccinated against

Published

on

Trump administration slashes number of diseases U.S. children will be regularly vaccinated against

The U.S. Department of Health and Human Services announced sweeping changes to the pediatric vaccine schedule on Monday, sharply cutting the number of diseases U.S. children will be regularly immunized against.

Under the new guidelines, the U.S. still recommends that all children be vaccinated against measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Haemophilus influenzae type B (Hib), pneumococcal disease, human papillomavirus (HPV) and varicella, better known as chickenpox.

Vaccines for all other diseases will now fall into one of two categories: recommended only for specific high-risk groups, or available through “shared clinical decision-making” — the administration’s preferred term for “optional.”

These include immunizations for hepatitis A and B, rotavirus, respiratory syncytial virus (RSV), bacterial meningitis, influenza and COVID-19. All these shots were previously recommended for all children.

Insurance companies will still be required to fully cover all childhood vaccines on the CDC schedule, including those now designated as optional, according to the Department of Health and Human Services.

Advertisement

Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, said in a statement that the new schedule “protects children, respects families, and rebuilds trust in public health.”

But pediatricians and public health officials widely condemned the shift, saying that it would lead to more uncertainty for patients and a resurgence of diseases that had been under control.

“The decision to weaken the childhood immunization schedule is misguided and dangerous,” said Dr. René Bravo, a pediatrician and president of the California Medical Assn. “Today’s decision undermines decades of evidence-based public health policy and sends a deeply confusing message to families at a time when vaccine confidence is already under strain.”

The American Academy of Pediatrics condemned the changes as “dangerous and unnecessary,” and said that it will continue to publish its own schedule of recommended immunizations. In September, California, Oregon, Washington and Hawaii announced that those four states would follow an independent immunization schedule based on recommendations from the AAP and other medical groups.

The federal changes have been anticipated since December, when President Trump signed a presidential memorandum directing the health department to update the pediatric vaccine schedule “to align with such scientific evidence and best practices from peer, developed countries.”

Advertisement

The new U.S. vaccination guidelines are much closer to those of Denmark, which routinely vaccinates its children against only 10 diseases.

As doctors and public health experts have pointed out, Denmark also has a robust system of government-funded universal healthcare, a smaller and more homogenous population, and a different disease burden.

“The vaccines that are recommended in any particular country reflect the diseases that are prevalent in that country,” said Dr. Kelly Gebo, dean of the Milken Institute School of Public Health at George Washington University. “Just because one country has a vaccine schedule that is perfectly reasonable for that country, it may not be at all reasonable” elsewhere.

Almost every pregnant woman in Denmark is screened for hepatitis B, for example. In the U.S., less than 85% of pregnant women are screened for the disease.

Instead, the U.S. has relied on universal vaccination to protect children whose mothers don’t receive adequate care during pregnancy. Hepatitis B has been nearly eliminated in the U.S. since the vaccine was introduced in 1991. Last month, a panel of Kennedy appointees voted to drop the CDC’s decades-old recommendation that all newborns be vaccinated against the disease at birth.

Advertisement

“Viruses and bacteria that were under control are being set free on our most vulnerable,” said Dr. James Alwine, a virologist and member of the nonprofit advocacy group Defend Public Health. “It may take one or two years for the tragic consequences to become clear, but this is like asking farmers in North Dakota to grow pineapples. It won’t work and can’t end well.”

Continue Reading

Trending